▲ Peaking
Health
Breakthrough: FDA Approves First Drug Offering a 'Functional Cure' For Chronic Hepatitis B
FDA and Health Canada approve GSK’s Hibsago, the first drug marketed as a functional cure for chronic hepatitis B.
1 trends tracked about this subject — the full history, oldest to newest below.
FDA and Health Canada approve GSK’s Hibsago, the first drug marketed as a functional cure for chronic hepatitis B.